FATE THERAPEUTICS INC Adjustments to Additional Paid in Capital, Warrant Issued
FATE THERAPEUTICS INC (FATE) reported Adjustments to Additional Paid in Capital, Warrant Issued of $217.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-02.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2020-03-02
- FATE THERAPEUTICS INC adjustments to additional paid in capital, warrant issued for the quarter ending 2017-09-30 was $217.00K.
- FATE THERAPEUTICS INC adjustments to additional paid in capital, warrant issued for fiscal 2017 was $217.00K.
- FATE THERAPEUTICS INC adjustments to additional paid in capital, warrant issued for fiscal 2014 was $375.00K, a 95.31% increase from fiscal 2013.
- FATE THERAPEUTICS INC adjustments to additional paid in capital, warrant issued for fiscal 2013 was $192.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2017-12-31 | $217.00K 10-K · filed 2020-03-02 | |
| 2017-09-30 | $217.00K 10-Q · filed 2018-11-01 | |
| 2014-12-31 | $375.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $192.00K 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |